Can probiotics change fish behavior?
Frank and her colleagues in Christina Semeniuk’s lab and comentor Daniel Heath’s lab at the University of Windsor in Ontario are trying to determine whether an unlikely intervention — a probiotic supplement in fish food — might help triploid Chinook salmon fare better. They’re starting with how the fish behave.
“Behavioral flexibility and sensitivity … would be an immediate measure for physiological (and neural genomic) change, given the connections between the gut–brain–behavior axis,” Semeniuk said.
Frank tested how probiotic supplements added to fish food affected the way hundreds of fingerling diploid and triploid fish respond to novel stimuli such as a glass bead tossed into the tank, a predator-shaped dummy passing overhead and an approaching human researcher. She will present her work as part of the Genomics poster session during the 2021 ASBMB annual meeting; you can see her talk and post questions while the meeting is underway.
In the future, Frank plans to integrate transcriptomic analyses with her behavioral studies, an approach known as behavioral genomics. Little is known about how triploidy affects genes related to learning and memory, so even if probiotics have little effect, she stands to learn something interesting.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Cholesterol regulatory genes predict liver transplant outcomes
Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.

Lipid signatures for a rare neurological disorder
Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.

Disease-linked mutations disrupt protein phase behavior
Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.

The dual role of asprosin in chronic fatty liver disease
Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.

Novel inhibitor targets RAS-driven cancers
Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.

Catching tau in the act
Using a new proximity-labeling approach, researchers reveal how tangles of the brain-associated protein tau may disrupt RNA biology long before neurons die.